Study S001495

Alleviating Carbohydrate Counting Using Weekly Subcutaneous Semaglutide Injections in People with Type 1 Diabetes on Closed-Loop Insulin Therapy: a 2x4 Factorial Randomized Placebo-Controlled Trial

ClinicalTrials.gov record

Registration

Registration: NCT06387199
Acronym: SEMA SMA
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 26
Start: 2024-12-01
Primary completion: 2027-01
Lead sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions: Type 1 Diabetes; Diabetes Mellitus
Interventions: DRUG:Semaglutide with 4 meal strategies; DRUG:Placebo with 4 meal strategies
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Percentage of daytime plasma glucose levels spent in target range (semaglutide vs. placebo) [24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.